Laura Chico
Stock Analyst at Wedbush
(4.79)
# 513
Out of 4,512 analysts
617
Total ratings
53.7%
Success rate
14.6%
Average return
Main Sectors:
Stocks Rated by Laura Chico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCRX BioCryst Pharmaceuticals | Maintained: Buy | $21 | $9.74 | +115.61% | 16 | Jul 13, 2026 | |
| BIIB Biogen | Rated: Hold | $196 → $201 | $191.95 | +4.71% | 68 | Jul 13, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Buy | $166 → $185 | $172.04 | +7.53% | 24 | Jul 13, 2026 | |
| TVTX Travere Therapeutics | Maintained: Buy | $61 | $57.06 | +6.91% | 34 | Jul 13, 2026 | |
| RARE Ultragenyx Pharmaceutical | Rated: Hold | $26 → $30 | $32.03 | -6.34% | 53 | Jul 13, 2026 | |
| ARDX Ardelyx | Maintained: Buy | $11 → $19 | $5.16 | +268.22% | 19 | Jul 13, 2026 | |
| VRDN Viridian Therapeutics | Maintained: Buy | $43 | $19.08 | +125.37% | 73 | Jul 13, 2026 | |
| DNLI Denali Therapeutics | Maintained: Buy | $23 → $26 | $22.65 | +14.79% | 27 | Jul 13, 2026 | |
| VERA Vera Therapeutics | Maintained: Hold | $47 → $43 | $43.13 | -0.30% | 11 | Jul 13, 2026 | |
| JBIO Jade Biosciences | Maintained: Buy | n/a | $21.34 | - | 11 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.24 | - | 6 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $3.72 | +222.58% | 7 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 | $39.73 | +30.88% | 25 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 | $101.28 | +3.67% | 15 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $166 → $162 | $327.68 | -50.56% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.1401 | +613.78% | 6 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $16 | $9.63 | +66.15% | 8 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $42.59 | +24.44% | 3 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $24 | $27.80 | -13.67% | 10 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $2.46 | +184.55% | 12 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $34.42 | +22.02% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $4 | $2.44 | +63.93% | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $48 | $29.88 | +60.64% | 6 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $16.11 | +148.29% | 3 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 | $67.30 | -6.39% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $29.13 | +30.45% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $7 | $3.16 | n/a | 10 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $16.01 | n/a | 4 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $13.67 | n/a | 8 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $5 | $5.70 | n/a | 5 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $4.44 | n/a | 4 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $45 | $0.9805 | n/a | 5 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $58.64 | n/a | 15 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $476.31 | n/a | 16 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.69 | n/a | 10 | Sep 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.93 | n/a | 4 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $656.12 | n/a | 16 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $9.03 | n/a | 1 | Jan 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.8348 | n/a | 1 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $45.35 | n/a | 1 | Dec 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $3.10 | n/a | 1 | Jun 30, 2017 |
BioCryst Pharmaceuticals
Jul 13, 2026
Maintained: Buy
Price Target: $21
Current: $9.74
Upside: +115.61%
Biogen
Jul 13, 2026
Rated: Hold
Price Target: $196 → $201
Current: $191.95
Upside: +4.71%
Neurocrine Biosciences
Jul 13, 2026
Maintained: Buy
Price Target: $166 → $185
Current: $172.04
Upside: +7.53%
Travere Therapeutics
Jul 13, 2026
Maintained: Buy
Price Target: $61
Current: $57.06
Upside: +6.91%
Ultragenyx Pharmaceutical
Jul 13, 2026
Rated: Hold
Price Target: $26 → $30
Current: $32.03
Upside: -6.34%
Ardelyx
Jul 13, 2026
Maintained: Buy
Price Target: $11 → $19
Current: $5.16
Upside: +268.22%
Viridian Therapeutics
Jul 13, 2026
Maintained: Buy
Price Target: $43
Current: $19.08
Upside: +125.37%
Denali Therapeutics
Jul 13, 2026
Maintained: Buy
Price Target: $23 → $26
Current: $22.65
Upside: +14.79%
Vera Therapeutics
Jul 13, 2026
Maintained: Hold
Price Target: $47 → $43
Current: $43.13
Upside: -0.30%
Jade Biosciences
Jul 10, 2026
Maintained: Buy
Price Target: n/a
Current: $21.34
Upside: -
Jul 10, 2026
Maintained: Buy
Price Target: n/a
Current: $13.24
Upside: -
Jun 30, 2026
Maintained: Buy
Price Target: $12
Current: $3.72
Upside: +222.58%
Jun 17, 2026
Maintained: Buy
Price Target: $52
Current: $39.73
Upside: +30.88%
Jun 15, 2026
Maintained: Buy
Price Target: $105
Current: $101.28
Upside: +3.67%
Jun 2, 2026
Maintained: Sell
Price Target: $166 → $162
Current: $327.68
Upside: -50.56%
May 19, 2026
Maintained: Hold
Price Target: $1
Current: $0.1401
Upside: +613.78%
May 18, 2026
Maintained: Buy
Price Target: $17 → $16
Current: $9.63
Upside: +66.15%
May 18, 2026
Maintained: Buy
Price Target: $53
Current: $42.59
Upside: +24.44%
May 14, 2026
Maintained: Hold
Price Target: $21 → $24
Current: $27.80
Upside: -13.67%
May 13, 2026
Maintained: Buy
Price Target: $7
Current: $2.46
Upside: +184.55%
May 13, 2026
Maintained: Buy
Price Target: $42
Current: $34.42
Upside: +22.02%
May 13, 2026
Maintained: Buy
Price Target: $5 → $4
Current: $2.44
Upside: +63.93%
May 13, 2026
Maintained: Buy
Price Target: $58 → $48
Current: $29.88
Upside: +60.64%
May 12, 2026
Reiterated: Buy
Price Target: $40
Current: $16.11
Upside: +148.29%
May 8, 2026
Maintained: Buy
Price Target: $63
Current: $67.30
Upside: -6.39%
May 8, 2026
Maintained: Buy
Price Target: $38
Current: $29.13
Upside: +30.45%
Aug 7, 2024
Maintained: Hold
Price Target: $8 → $7
Current: $3.16
Upside: n/a
Apr 11, 2024
Maintained: Buy
Price Target: $13 → $11
Current: $16.01
Upside: n/a
Mar 20, 2024
Maintained: Hold
Price Target: $5
Current: $13.67
Upside: n/a
Aug 12, 2022
Maintained: Buy
Price Target: $22 → $5
Current: $5.70
Upside: n/a
Feb 11, 2022
Maintained: Buy
Price Target: $23
Current: $4.44
Upside: n/a
Aug 11, 2020
Maintained: Hold
Price Target: $3 → $45
Current: $0.9805
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $58.64
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $476.31
Upside: n/a
Sep 12, 2018
Downgraded: Hold
Price Target: n/a
Current: $14.69
Upside: n/a
Aug 13, 2018
Maintained: Hold
Price Target: n/a
Current: $1.93
Upside: n/a
Aug 8, 2018
Maintained: Hold
Price Target: n/a
Current: $656.12
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $24
Current: $9.03
Upside: n/a
Jan 4, 2018
Reiterated: Hold
Price Target: n/a
Current: $0.8348
Upside: n/a
Dec 7, 2017
Reiterated: Buy
Price Target: n/a
Current: $45.35
Upside: n/a
Jun 30, 2017
Maintained: Buy
Price Target: $30
Current: $3.10
Upside: n/a